What Is Wegovy? A Complete Guide to Semaglutide for Weight Loss

Wegovy (semaglutide) is an FDA-approved weekly injection for chronic weight management in adults and certain adolescents with obesity or weight-related health conditions. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a natural hormone that regulates appetite and blood sugar. Wegovy has become one of the most talked-about medications in recent memory — and for good reason. Clinical trials show it can help people lose significantly more weight than diet and exercise alone. Here's everything you need to know.

---

The Big Picture: What Exactly Is Wegovy?

Wegovy is a prescription medication made by Novo Nordisk. Its active ingredient is semaglutide — the same molecule found in the diabetes drug Ozempic, but at a higher dose specifically formulated for weight management.

It comes as a pre-filled, single-use injection pen that you use once a week. You inject it under the skin (subcutaneously) in your stomach, thigh, or upper arm — whichever you and your doctor decide works best for your routine.

Wegovy isn't a stimulant. It isn't a diet pill. It's a hormone-based therapy that works with your body's own appetite and satiety signals to help you eat less without feeling deprived. For a deeper look at the mechanism, see how Wegovy works.

---

FDA-Approved Uses

The FDA has approved Wegovy for two specific purposes:

1. Chronic Weight Management in Adults

Wegovy is approved for long-term weight management in adults who meet at least one of these criteria:

• A body mass index (BMI) of 30 or higher (classified as obesity), OR
• A BMI of 27 or higher (classified as overweight) plus at least one weight-related health condition, such as:
  • High blood pressure (hypertension)
  • Type 2 diabetes
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea

The FDA approval specifies that Wegovy should be used alongside a reduced-calorie diet and increased physical activity — not as a standalone fix.

2. Chronic Weight Management in Adolescents (Ages 12 and Older)

In 2022, the FDA expanded Wegovy's approval to include adolescents aged 12 and older with obesity (BMI at or above the 95th percentile for age and sex). This made Wegovy the first medication approved in decades specifically for weight management in teenagers.

3. Cardiovascular Risk Reduction

In 2024, the FDA approved an additional indication: reducing the risk of serious cardiovascular events — including heart attack and stroke — in adults with established cardiovascular disease who are also overweight or obese. This approval was based on the landmark SELECT trial, which showed a 20% reduction in major cardiovascular events compared to placebo.

This makes Wegovy more than just a weight-loss drug. For patients with heart disease carrying extra weight, it can be a genuine heart-protective therapy.

---

Common Off-Label Uses

Doctors sometimes prescribe medications for purposes beyond their FDA-approved indications. With Wegovy and semaglutide more broadly, a few off-label uses have gained traction:

Type 2 Diabetes (Weight Management Component) Ozempic — not Wegovy — is the FDA-approved semaglutide product for type 2 diabetes. However, some prescribers use Wegovy off-label in diabetic patients when weight loss is the primary goal. Your doctor will determine which semaglutide product makes more sense for your situation.

Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) Early research suggests semaglutide may reduce liver fat and inflammation in patients with non-alcoholic steatohepatitis (NASH). This is still an active area of investigation and not a standard prescribing indication yet.

Polycystic Ovary Syndrome (PCOS) Some physicians prescribe semaglutide off-label for women with PCOS, since weight loss can significantly improve hormonal balance and metabolic markers in this population.

Important: Off-label use doesn't mean unsafe — it means the FDA hasn't formally reviewed that specific use. Always have a detailed conversation with your doctor about why a medication is being prescribed and what the evidence shows.

---

How Wegovy Is Supplied: Dosage Forms and Strengths

Wegovy comes in five dose strengths, each in a pre-filled injection pen:

Each pen delivers a single weekly dose. You'll work through the escalation schedule gradually — this step-up approach is intentional. It gives your body time to adjust and helps minimize side effects, particularly nausea and digestive discomfort.

The pens are for single use only. After your injection, the pen is disposed of safely (typically in a sharps container). You do not mix or measure anything — the dose is pre-loaded.

Storage note: Wegovy pens should be stored in the refrigerator (36°F to 46°F / 2°C to 8°C). If needed, a single pen can be kept at room temperature (up to 77°F) for up to 28 days.

---

Typical Dosing Schedule

The standard Wegovy dosing escalation looks like this:

• Weeks 1–4: 0.25 mg once weekly
• Weeks 5–8: 0.5 mg once weekly
• Weeks 9–12: 1 mg once weekly
• Weeks 13–16: 1.7 mg once weekly
• Week 17 onward: 2.4 mg once weekly (maintenance)

If you have trouble tolerating a higher dose — nausea, vomiting, or other GI side effects — your doctor may slow the escalation. Some patients stay at 1.7 mg long-term if they can't tolerate 2.4 mg.

You take Wegovy on the same day each week, at any time of day, with or without food. If you miss a dose and your next scheduled dose is more than 2 days away, you can take the missed dose. If it's less than 2 days away, skip it and resume your regular schedule.

---

Who Should NOT Take Wegovy: Contraindications

Wegovy is not right for everyone. Your doctor will review your full medical history before prescribing it. The following are established contraindications — meaning Wegovy should generally not be used if you have:

Personal or Family History of Medullary Thyroid Carcinoma (MTC)

In animal studies, semaglutide caused thyroid tumors, including medullary thyroid carcinoma. It's not yet known whether this applies to humans, but the FDA requires a Boxed Warning (the most serious type) for this risk. If you or a blood relative has had MTC, Wegovy is off the table.

Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)

This is a genetic syndrome that significantly raises the risk of MTC, among other tumors. Wegovy is contraindicated in anyone with MEN 2.

Serious Hypersensitivity to Semaglutide

If you've had a severe allergic reaction (anaphylaxis, angioedema) to semaglutide or any ingredient in Wegovy, you should not use it.

Pregnancy

Wegovy is not recommended during pregnancy. Weight loss is generally not advised while pregnant, and animal studies have shown potential harm to developing fetuses. If you become pregnant while on Wegovy, notify your doctor immediately. Women of childbearing age should discuss contraception with their provider before starting treatment.

---

Key Warnings and Precautions

Beyond the hard contraindications, there are several important warnings your doctor will walk you through:

⚠️ Thyroid Tumors (Boxed Warning)

As noted above, the FDA's most prominent warning on Wegovy relates to thyroid C-cell tumors seen in animal studies. Tell your doctor right away if you notice a lump or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath.

⚠️ Pancreatitis

Cases of pancreatitis (inflammation of the pancreas) have been reported with GLP-1 receptor agonists. Symptoms include severe, persistent abdominal pain that may radiate to your back. If this happens, stop Wegovy and get medical attention. Wegovy should not be restarted if pancreatitis is confirmed.

⚠️ Gallbladder Problems

Rapid weight loss — from any cause — can increase the risk of gallstones. Wegovy-related gallbladder disease and cholecystitis (gallbladder inflammation) have been reported in clinical trials. Tell your doctor if you develop upper abdominal pain, fever, or jaundice.

⚠️ Low Blood Sugar (Hypoglycemia)

Wegovy alone rarely causes low blood sugar in non-diabetic patients. However, if you also take insulin or a sulfonylurea (a common diabetes medication), the combination can cause hypoglycemia. Your diabetes medications may need to be adjusted when you start Wegovy.

⚠️ Heart Rate Increase

Wegovy can cause a small increase in resting heart rate. Your doctor may monitor this, especially if you have a heart condition. Report any persistent, rapid, or pounding heartbeat to your healthcare provider.

⚠️ Kidney Problems

Severe nausea, vomiting, or diarrhea from Wegovy can lead to dehydration, which may worsen kidney function — particularly in people with existing kidney disease. Stay well hydrated, especially during the dose escalation phase.

⚠️ Diabetic Retinopathy Complications

In patients with type 2 diabetes and pre-existing diabetic retinopathy, rapid improvements in blood sugar control have been associated with worsening of retinopathy. If you have a history of retinopathy, your doctor will want to monitor your eye health.

⚠️ Depression and Suicidal Ideation

The FDA has asked manufacturers of GLP-1 drugs to monitor and report mental health-related adverse events. If you experience worsening depression, mood changes, or any thoughts of self-harm while on Wegovy, contact your doctor or a mental health professional immediately.

For a comprehensive breakdown of Wegovy's side effect profile — from the most common (nausea, constipation) to the more serious — see Wegovy side effects.

---

How Wegovy Differs from Similar Drugs

You've probably heard of Ozempic, Mounjaro, and Zepbound. Here's a quick orientation:

Wegovy and Ozempic contain the same active ingredient at different approved doses for different purposes. Wegovy is not interchangeable with Ozempic, even though some patients and providers have used one in place of the other during shortage periods — always under medical supervision.

For details on how semaglutide interacts with other medications you might be taking, see Wegovy drug interactions.

---

The Bottom Line

Wegovy represents a meaningful shift in how medicine approaches weight management. It's not a quick fix — it requires commitment, lifestyle changes, and ongoing medical oversight. But for people who qualify, it can produce weight loss that simply wasn't achievable through diet and exercise alone, while also offering cardiovascular benefits that extend well beyond the scale.

If you think Wegovy might be right for you, the conversation starts with your doctor. They can assess whether you meet the criteria, review your medical history for contraindications, and help you set realistic expectations for what treatment looks like.

---

Frequently Asked Questions

Is Wegovy the same as Ozempic?

They contain the same active ingredient — semaglutide — but they are not the same product. Ozempic is approved for type 2 diabetes management at doses up to 2 mg. Wegovy is approved for chronic weight management at a 2.4 mg maintenance dose. The higher dose, the specific pen design, and the FDA-approved indications are different. Your insurance coverage may also differ significantly between the two.

How long does it take for Wegovy to work?

Most people begin to see weight loss within the first four weeks, though meaningful results typically build over the first three to six months as the dose escalates. Clinical trials showed the greatest weight loss occurring over approximately 68 weeks at the full 2.4 mg maintenance dose. Results vary significantly based on diet, activity level, starting weight, and individual response.

Is Wegovy covered by insurance?

Coverage varies widely. Some commercial insurance plans cover Wegovy, particularly when obesity-related comorbidities are documented. Medicare and Medicaid coverage has historically been limited for weight-loss medications, though this is evolving. Novo Nordisk also offers a savings program for eligible commercially insured patients. Your pharmacist or prescriber's office can help you navigate prior authorization requirements.

What happens if I stop taking Wegovy?

Research shows that most patients regain a significant portion of lost weight within one to two years of stopping Wegovy. This reflects the chronic nature of obesity as a disease — the medication helps manage it, but it doesn't cure it. Your doctor can help you develop a long-term plan, whether that involves continuing the medication or transitioning to a maintenance strategy.

---

Need help finding Wegovy in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Wegovy Near You →

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →